A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)
Simple Summary: Avelumab maintenance therapy is approved in Japan for patients with advanced urothelial carcinoma (aUC) who have not seen their cancer progress after receiving platinum-based chemotherapy (PBC). This study provides important information about how effective avelumab is for these patie...
| Publicado en: | Current Oncology Vol. 32; no. 11; pp. 618 - 634 |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Nov2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |